MAPK9 and colorectal cancer: Failure to alleviate JNK2-mediated suppression of JNK1/c-Jun would similarly favour tumour formation, and this is supported by our evidence for constitutive JNK2-mediated suppression of JNK1/c-Jun in a range of human colorectal cancer cell lines (this paper).